The TCL technology platform has been validated, both in laboratory tests and in pre-clinical studies.
TCL Heart Analyzer™ (the CHF application of TCL Analyzer™) was used in pre-clinical prediction studies of CHF and CHF deterioration. The studies demonstrated the device validity as a decision-support tool.
Correlation between TCL Fertility-AID™ (the IVF application of TCL Analyzer™) indications and vitality of embryos has been demonstrated in pre-clinical studies.
Intellectual Property is protected by international patents.
Carmel Diagnostics is searching for strategic partners to complete pre-clinical studies, to carry out regulation procedures, and to bring products to market. Different adequate business models may be considered.